WallStSmart

Intuitive Surgical Inc (ISRG)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Intuitive Surgical Inc generates 256% more annual revenue ($11.03B vs $3.10B). ISRG leads profitability with a 28.4% profit margin vs -10.7%. ISRG earns a higher WallStSmart Score of 66/100 (B-).

ISRG

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.0Quality: 7.8
Piotroski: 4/9Altman Z: 5.95

MMED

Hold

37

out of 100

Grade: F

Growth: 6.7Profit: 4.0Value: 5.0Quality: 6.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ISRGUndervalued (+81.6%)

Margin of Safety

+81.6%

Fair Value

$1922.89

Current Price

$368.26

$1554.63 discount

UndervaluedFair: $1922.89Overvalued

Intrinsic value data unavailable for MMED.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ISRG6 strengths · Avg: 9.0/10
Operating MarginProfitability
33.8%10/10

Strong operational efficiency at 33.8%

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Market CapQuality
$122.06B9/10

Large-cap with strong market position

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
18.5%8/10

18.5% revenue growth

EPS GrowthGrowth
26.5%8/10

Earnings expanding 26.5% YoY

MMED3 strengths · Avg: 9.3/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
15.6%8/10

15.6% revenue growth

Areas to Watch

ISRG2 concerns · Avg: 3.0/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
40.2x2/10

Premium valuation, high expectations priced in

MMED4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-226.00M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-10.7%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ISRG

The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.8%. Revenue growth of 18.5% demonstrates continued momentum.

Bull Case : MMED

The strongest argument for MMED centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 15.6% demonstrates continued momentum.

Bear Case : ISRG

The primary concerns for ISRG are PEG Ratio, P/E Ratio. A P/E of 40.2x leaves little room for execution misses.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Free Cash Flow.

Key Dynamics to Monitor

ISRG is growing revenue faster at 18.5% — sustainability is the question.

ISRG generates stronger free cash flow (948M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ISRG scores higher overall (66/100 vs 37/100), backed by strong 28.4% margins and 18.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Intuitive Surgical Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

MiniMed Group, Inc. Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?